Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000339
Status:
UNKNOWN
Last Update Posted:
2017-01-11
First Post:
1999-09-20
Brief Title:
Infusion Laboratory Protocol 3 Risperidone - 4
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Infusion Laboratory Protocol 3 Risperidone
Status:
UNKNOWN
Status Verified Date:
1996-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate clinical safety issues pertaining to risperidone to cocaine and to its interaction and to determine how pretreatment with risperidone modifies the subjective as well as physiological effects of cocaine
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Y01-3-0010-4 | None | None | None |